Xplico was established in 2005 with the purpose to develop and market an easy-to-use and standardized tool for valuation of projects and portfolios in the life science industry. Xplico is today the market leader in valuation, supporting more than 100 life science companies in EU, US and Asia on a daily basis.

Currently, Xplico markets three solutions:

Xplico Evaluator is an easy-to-use, flexible valuation tool with integrated risk assessment and powerful analysis features for the life science industry.

Xplico CapTable is an easy-to-use standardized Excel-based tool which is built and tailored to keeping accurate track of multiple ownership and exit scenarios.

Consulting services. We have extensive experience in valuation, forecasting and project/portfolio management and our team of consultants can evaluate your projects and/or company or support you during partnering negotiations.

News from the Xplico world



JPM 2026, 12 - 15 January, 2026, San Francisco, California.

This premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Health Community features the leading innovators and latest innovations from around the world which are addressing today’s health and wellness challenges. Learn how the latest advances, leading research and best practices are being applied to grow and scale digital health solutions.

 

(August 2025)


Bio Europe Spring March 23–25, 2026

2026-BES

BIO-Europe is the gateway to the global biopharma community and celebrates 30 years of facilitating partnerships. 

The conference convenes over 5,500 attendees, representing 60 countries and 2,800+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

 

(August 2025)


Bio Convention June 22-25, 2026 | San Diego, CA.

2026-BIC

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. The proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

(August 2025)


Xplico elected a Gazelle Company for the 4th year in a row

We are proud to announce that Xplico has been elected a Gazelle company for the 4th year in a row.

The election is organized by the Danish financial newspaper Børsen, and the requirements to become a Gazelle company are tough. A Gazelle business is continuously growing and, as a minimum, doubles its revenue or gross profit over four fiscal years, while maintaining positive growth throughout the years.

(October 2024)